Madrigal Pharmaceuticals (MDGL) Short Interest Ratio & Short Volume

$284.49

+1.03 (+0.36%)

(As of 07/26/2024 ET)

Compare

Madrigal Pharmaceuticals Short Interest Data

Current Short Interest: 4,110,000 shares
Previous Short Interest: 4,080,000 shares
Change Vs. Previous Month: +0.74%
Dollar Volume Sold Short: $1.15 billion
Short Interest Ratio: 9.1 Days to Cover
Last Record Date: July 15, 2024

Outstanding Shares: 21,310,000 shares
Percentage of Shares Shorted: 19.29%
Today's Trading Volume: 167,769 shares
Average Trading Volume: 291,202 shares
Today's Volume Vs. Average: 58%

cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Short Selling Madrigal Pharmaceuticals ?

Sign up to receive the latest short interest report for Madrigal Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Short Interest Chart Days to Cover Chart Short Percent of Float Chart

MDGL Short Interest Over Time

MDGL Days to Cover Over Time

MDGL Percentage of Float Shorted Over Time

Ad WealthPress

This TSLA short trade is on a nine win hot streak

Most Tesla Shareholders are disappointed in the stock's performance in 2024. Year to date, it's down 30%... And things don’t seem to be getting better. That said, one professional trader has found a way to turn Tesla’s demise into a flurry of opportunity… In fact, he has not lost a single trade on Tesla this year. As of this mailing he’s 9 for 9 with incredible wins under his belt. Just see for yourself.

But I can promise that you’ll see all the details for yourself here.

Madrigal Pharmaceuticals Short Interest History

Export to Excel

Report Date	Total Shares Sold Short	Dollar Volume Sold Short	Change from Previous Report	Percentage of Float Shorted	Days to Cover	Price on Report Date
7/15/2024	4,110,000 shares	$1.15 billion	+0.7%	N/A	9.1	$279.95
6/30/2024	4,080,000 shares	$1.14 billion	-7.9%	N/A	9.1	$280.16
6/15/2024	4,430,000 shares	$1.23 billion	-15.3%	N/A	9.5	$277.59
5/31/2024	5,230,000 shares	$1.24 billion	+25.4%	N/A	9.4	$236.16
5/15/2024	4,170,000 shares	$882.91 million	+4.8%	N/A	8.1	$211.73
4/30/2024	3,980,000 shares	$812.00 million	+16.7%	N/A	6.9	$204.02
Get the Latest News and Ratings for MDGL and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Madrigal Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.
4/15/2024	3,410,000 shares	$788.97 million	+1.5%	N/A	5.9	$231.37
3/31/2024	3,360,000 shares	$897.25 million	+3.1%	N/A	6	$267.04
3/15/2024	3,260,000 shares	$881.41 million	-5.8%	20.2%	5.9	$270.37
2/29/2024	3,460,000 shares	$817.25 million	+2.1%	21.4%	7.3	$236.20
2/15/2024	3,390,000 shares	$753.33 million	+8.0%	21.1%	7.6	$222.22
1/31/2024	3,140,000 shares	$680.47 million	-5.1%	19.5%	7.2	$216.71
1/15/2024	3,310,000 shares	$780.50 million	+1.9%	21.1%	8.6	$235.80
12/31/2023	3,250,000 shares	$751.99 million	+5.9%	20.7%	7.9	$231.38
12/15/2023	3,070,000 shares	$727.99 million	-11.5%	19.5%	6.7	$237.13
11/30/2023	3,470,000 shares	$705.45 million	+0.3%	24.4%	7.1	$203.30
11/15/2023	3,460,000 shares	$559.41 million	+1.5%	24.3%	7.7	$161.68
10/31/2023	3,410,000 shares	$448.01 million	+13.3%	24.7%	8.2	$131.38
10/15/2023	3,010,000 shares	$422.51 million	+13.6%	21.8%	7.6	$140.37
9/30/2023	2,650,000 shares	$387.01 million	+24.4%	19.2%	7.4	$146.04
9/15/2023	2,130,000 shares	$374.65 million	+8.7%	16.5%	6.3	$175.89
8/31/2023	1,960,000 shares	$352.80 million	+8.3%	15.2%	6.3	$180.00
8/15/2023	1,810,000 shares	$315.25 million	-1.1%	14.0%	5.7	$174.17
7/31/2023	1,830,000 shares	$375.70 million	-3.2%	13.8%	5.3	$205.30
7/15/2023	1,890,000 shares	$426.71 million	+7.4%	14.3%	5.4	$225.77
6/30/2023	1,760,000 shares	$406.56 million	+10.0%	13.3%	4.7	$231.00
6/15/2023	1,600,000 shares	$408.85 million	+10.3%	12.1%	4.7	$255.53
5/31/2023	1,450,000 shares	$403.69 million	+15.1%	10.4%	3.9	$278.41
5/15/2023	1,260,000 shares	$365.77 million	-8.7%	9.0%	3.1	$290.29
4/30/2023	1,380,000 shares	$430.56 million	-6.8%	10.0%	3.3	$312.00
4/15/2023	1,480,000 shares	$354.89 million	+19.4%	10.8%	3.7	$239.79
3/31/2023	1,240,000 shares	$300.40 million	+3.3%	9.2%	3.1	$242.26
3/15/2023	1,200,000 shares	$286.57 million	+16.5%	8.7%	2.3	$238.81
2/28/2023	1,030,000 shares	$279.14 million	+9.2%	7.4%	1.6	$271.01
2/15/2023	942,900 shares	$266.14 million	0.0%	7.2%	1.5	$282.26
1/31/2023	943,300 shares	$271.91 million	-3.3%	7.2%	1.6	$288.25
1/15/2023	975,300 shares	$292.57 million	-12.9%	7.5%	1.6	$299.98
12/30/2022	1,120,000 shares	$325.08 million	-52.7%	9.0%	1.9	$290.25
12/15/2022	2,370,000 shares	$149.07 million	+9.7%	19.1%	4.3	$62.90
11/30/2022	2,160,000 shares	$151.44 million	+3.9%	17.4%	7.3	$70.11
Prepare for a Recession Unlike Any Other (Ad) Dave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW. GET THE FREE GUIDE
11/15/2022	2,080,000 shares	$146.68 million	+14.3%	16.8%	7.9	$70.52
10/31/2022	1,820,000 shares	$128.89 million	+17.4%	14.7%	7.4	$70.82
10/15/2022	1,550,000 shares	$100.27 million	+1.3%	12.5%	6.6	$64.69
9/30/2022	1,530,000 shares	$99.43 million	+2.7%	12.4%	7.2	$64.99
9/15/2022	1,490,000 shares	$103.70 million	+1.4%	12.1%	7.4	$69.60
8/31/2022	1,470,000 shares	$106.02 million	-4.6%	11.9%	7.8	$72.12
8/15/2022	1,540,000 shares	$118.13 million	-3.8%	12.5%	8.6	$76.71
7/31/2022	1,600,000 shares	$100.51 million	+3.2%	12.9%	8.4	$62.82
7/15/2022	1,550,000 shares	$107.24 million	-4.3%	12.5%	8.1	$69.19
6/30/2022	1,620,000 shares	$115.96 million	-2.4%	13.1%	8.1	$71.58
6/15/2022	1,660,000 shares	$112.71 million	+3.8%	13.4%	8.6	$67.90
5/31/2022	1,600,000 shares	$106.22 million	-5.3%	12.9%	8.5	$66.39
5/15/2022	1,690,000 shares	$111.08 million	-2.9%	13.6%	8.8	$65.73
4/30/2022	1,740,000 shares	$121.80 million	+1.8%	14.0%	8.2	$70.00
4/15/2022	1,710,000 shares	$135.89 million	-5.5%	13.8%	7.3	$79.47
3/31/2022	1,810,000 shares	$177.60 million	-9.1%	14.6%	7.8	$98.12
3/15/2022	1,990,000 shares	$179.10 million	+0.5%	16.0%	8.5	$90.00
2/28/2022	1,980,000 shares	$183.84 million	-1.5%	16.0%	8.1	$92.85
2/15/2022	2,010,000 shares	$180.72 million	+12.3%	16.2%	8.4	$89.91
1/31/2022	1,790,000 shares	$103.07 million	+19.3%	14.4%	8.5	$57.58
1/15/2022	1,500,000 shares	$117.68 million	+8.7%	12.1%	9.4	$78.45
12/31/2021	1,380,000 shares	$116.94 million	-6.8%	11.1%	9.6	$84.74
12/15/2021	1,480,000 shares	$110.82 million	+7.3%	11.9%	10.8	$74.88
11/30/2021	1,380,000 shares	$114.14 million	+2.2%	12.0%	12	$82.71
11/15/2021	1,350,000 shares	$122.00 million	-3.6%	11.8%	12.7	$90.37
10/29/2021	1,400,000 shares	$108.85 million	+3.7%	12.2%	13.3	$77.75
10/15/2021	1,350,000 shares	$116.33 million	-6.9%	12.1%	13.5	$86.17
9/30/2021	1,450,000 shares	$115.70 million	No Change	13.0%	14.1	$79.79
9/15/2021	1,450,000 shares	$115.10 million	-7.1%	13.0%	11.9	$79.38
8/31/2021	1,560,000 shares	$129.09 million	-5.5%	14.0%	12.2	$82.75
8/13/2021	1,650,000 shares	$140.02 million	+3.1%	14.8%	10.9	$84.86
7/30/2021	1,600,000 shares	$139.71 million	-4.2%	14.4%	10.4	$87.32
7/15/2021	1,670,000 shares	$157.95 million	No Change	15.0%	11	$94.58
6/30/2021	1,670,000 shares	$162.67 million	-5.1%	15.0%	10.9	$97.41
6/15/2021	1,760,000 shares	$185.66 million	-7.9%	15.8%	12.4	$105.49
5/28/2021	1,910,000 shares	$214.49 million	-7.3%	17.2%	14.1	$112.30
5/14/2021	2,060,000 shares	$271.12 million	+1.0%	18.9%	16.5	$131.61
4/30/2021	2,040,000 shares	$280.68 million	-8.5%	18.7%	14.8	$137.59
4/15/2021	2,230,000 shares	$269.70 million	-5.1%	21.8%	12.3	$120.94
3/31/2021	2,350,000 shares	$273.80 million	-4.5%	23.4%	12.7	$116.51
3/15/2021	2,460,000 shares	$289.89 million	-7.5%	24.5%	12.4	$117.84
2/26/2021	2,660,000 shares	$327.34 million	-4.0%	26.5%	13.5	$123.06
2/12/2021	2,770,000 shares	$334.67 million	+5.3%	28.6%	14.4	$120.82
1/29/2021	2,630,000 shares	$304.11 million	-8.4%	26.0%	13.7	$115.63
1/15/2021	2,870,000 shares	$327.18 million	+4.7%	28.4%	17.9	$114.00
12/31/2020	2,740,000 shares	$304.47 million	+12.3%	27.1%	19.3	$111.12
12/15/2020	2,440,000 shares	$294.58 million	-2.4%	24.2%	17.2	$120.73
11/30/2020	2,500,000 shares	$297.78 million	+5.5%	24.8%	16.9	$119.11
11/15/2020	2,370,000 shares	$303.57 million	-4.4%	23.5%	16.3	$128.09
10/30/2020	2,480,000 shares	$318.23 million	+0.8%	24.6%	18.5	$128.32
Prepare for a Recession Unlike Any Other (Ad) Dave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW. GET THE FREE GUIDE
10/15/2020	2,460,000 shares	$312.94 million	No Change	24.4%	19.1	$127.21
9/30/2020	2,460,000 shares	$292.08 million	-13.7%	24.4%	19.4	$118.73
9/15/2020	2,850,000 shares	$304.72 million	+2.5%	28.3%	21.4	$106.92
8/31/2020	2,780,000 shares	$299.41 million	-1.8%	27.6%	25	$107.70
8/14/2020	2,830,000 shares	$301.37 million	+0.4%	32.6%	24.3	$106.49
7/31/2020	2,820,000 shares	$289.36 million	+0.7%	32.6%	18.9	$102.61
7/15/2020	2,800,000 shares	$291.00 million	-4.8%	32.4%	16.4	$103.93
6/30/2020	2,940,000 shares	$302.06 million	+1.0%	34.1%	14.9	$102.74
6/15/2020	2,910,000 shares	$314.43 million	+1.8%	33.7%	13.9	$108.05
5/29/2020	2,860,000 shares	$332.96 million	-8.6%	33.1%	12.5	$116.42
5/15/2020	3,130,000 shares	$370.59 million	-7.7%	37.2%	13.3	$118.40
4/30/2020	3,390,000 shares	$283.68 million	No Change	40.3%	16.4	$83.68
4/15/2020	3,390,000 shares	$250.11 million	+16.5%	34.3%	16.8	$73.78
3/31/2020	2,910,000 shares	$263.21 million	+18.8%	29.5%	15.6	$90.45
3/13/2020	2,450,200 shares	$164.63 million	-3.5%	24.8%	14.5	$67.19
2/28/2020	2,540,000 shares	$176.40 million	-1.9%	25.7%	13.2	$69.45
2/14/2020	2,590,000 shares	$222.25 million	+0.8%	26.2%	13.9	$85.81
1/31/2020	2,570,000 shares	$217.22 million	+6.6%	26.0%	13.5	$84.52
1/15/2020	2,410,000 shares	$218.25 million	+1.7%	24.4%	12.9	$90.56
12/31/2019	2,370,000 shares	$182.44 million	-1.3%	24.0%	13.7	$76.98

MDGL Short Interest - Frequently Asked Questions

What is Madrigal Pharmaceuticals' current short interest?: Short interest is the volume of Madrigal Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of July 15th, investors have sold 4,110,000 shares of MDGL short. Learn More on Madrigal Pharmaceuticals' current short interest.
What is a good short interest ratio for Madrigal Pharmaceuticals?: The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MDGL shares currently have a short interest ratio of 9.0. Learn More on Madrigal Pharmaceuticals's short interest ratio.
Which institutional investors are shorting Madrigal Pharmaceuticals?: As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Madrigal Pharmaceuticals: Walleye Trading LLC, Ikarian Capital LLC, Jane Street Group LLC, PEAK6 Investments LLC, and Twin Tree Management LP. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.
Is Madrigal Pharmaceuticals' short interest increasing or decreasing?: Madrigal Pharmaceuticals saw a increase in short interest in the month of July. As of July 15th, there was short interest totaling 4,110,000 shares, an increase of 0.7% from the previous total of 4,080,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Madrigal Pharmaceuticals' short interest compare to its competitors?: Here is how the short interest of companies in the sector of "medical" compare to Madrigal Pharmaceuticals: Rocket Pharmaceuticals, Inc. (10.62%), Y-mAbs Therapeutics, Inc. (11.70%), Generation Bio Co. (3.93%), BioMarin Pharmaceutical Inc. (3.93%), United Therapeutics Co. (9.57%), Incyte Co. (5.70%), Neurocrine Biosciences, Inc. (2.61%), Exact Sciences Co. (7.58%), Repligen Co. (8.14%), Ionis Pharmaceuticals, Inc. (6.98%),
Which stocks are the most shorted right now?: As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.13 billion), Royal Caribbean Cruises Ltd. ($2.77 billion), Moderna, Inc. ($2.76 billion), Coinbase Global, Inc. ($2.36 billion), Rivian Automotive, Inc. ($2.22 billion), Paychex, Inc. ($2.02 billion), Tractor Supply ($1.81 billion), Enphase Energy, Inc. ($1.65 billion), Chesapeake Energy Co. ($1.62 billion), and Lululemon Athletica Inc. ($1.58 billion). View all of the most shorted stocks.
What does it mean to sell short Madrigal Pharmaceuticals stock?: Short selling MDGL is an investing strategy that aims to generate trading profit from Madrigal Pharmaceuticals as its price is falling. MDGL shares are trading up $1.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.
How does a short squeeze work against Madrigal Pharmaceuticals?: A short squeeze for Madrigal Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of MDGL, which in turn drives the price of the stock up even further.
How often is Madrigal Pharmaceuticals' short interest reported?: Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MDGL, twice per month. The most recent reporting period available is July, 15 2024.